skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 2
Patent #:
NONE
Issue Dt:
Application #:
10517079
Filing Dt:
08/11/2005
Publication #:
Pub Dt:
09/25/2008
Inventors:
Mattias Hallbrink, Margus Pooga, Madis Metsis, Priit Kogerman, Andreas Valkna et al
Title:
Cell Penetrating Peptides
Assignment: 1
Reel/Frame:
016869/0933Recorded: 08/10/2005Pages: 58
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
07/15/2005
Exec Dt:
07/05/2005
Exec Dt:
07/05/2005
Exec Dt:
07/11/2005
Exec Dt:
07/11/2005
Exec Dt:
07/11/2005
Exec Dt:
07/15/2005
Exec Dt:
07/15/2005
Exec Dt:
07/15/2005
Exec Dt:
07/04/2005
Exec Dt:
07/04/2005
Exec Dt:
07/04/2005
Exec Dt:
07/15/2005
Exec Dt:
07/05/2005
Exec Dt:
07/15/2005
Exec Dt:
07/15/2005
Exec Dt:
07/15/2005
Exec Dt:
07/15/2005
Exec Dt:
07/05/2005
Exec Dt:
07/15/2005
Assignee:
C/O HEALTHCAP AB
STRANDVAGEN 5B
STOCKHOLM, SWEDEN SE-114 51
Correspondent:
MICHAEL L. GOLDMAN, ESQ.
NIXON PEABODY LLP
CLINTON SQUARE, P.O. BOX 31051
ROCHESTER, NY 14603-1051
Assignment: 2
Reel/Frame:
019479/0221Recorded: 06/26/2007Pages: 4
Conveyance:
CORRECTIVE ASSIGNMENT TO CORRECT THE SERIAL NUMBER 11519079 PREVIOUSLY RECORDED ON REEL 019471 FRAME 0800. ASSIGNOR(S) HEREBY CONFIRMS THE SERIAL NUMBER 10517079.
Assignor:
Exec Dt:
06/19/2007
Assignee:
BOX 45029
STOCKHOLM, SWEDEN S-104 30
Correspondent:
NIXON PEABODY LLP - PATENT GROUP
CLINTON SQUARE, P.O. BOX 31051
ROCHESTER, NY 14063-1051

Search Results as of: 06/19/2024 02:14 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT